Chepstow, 13 November 2023 – IQ Endoscopes is delighted to announce that it has achieved UKCA regulatory approval on its first product, the Q Vision G-100 Gastroscope. This approval is the first step in IQE’s regulatory strategy to bring a range of clinically acceptable, sustainable single use endoscopes to market. Our aim is to enter the market with a platform of sustainable single use endoscopes to support capacity issues in the NHS and worldwide.
Related: Recor Medical receives FDA approval for hypertension treatment system
Matt Ginn, CEO at IQ Endoscopes, commented: “We are thrilled to announce this great achievement by the team. Regulatory approval is a hugely important part of our strategy and we can’t wait to build on this success ready to bring product to market”
Chris Jenkins, Head of QARAC at IQ Endoscopes, said: “I would like to take this opportunity to thank the team for all their hard work in helping us reach this significant milestone. Quality and regulatory has always been valued highly at IQ Endoscopes and I am looking forward to continuing our efforts with some exciting things to look forward to in 2024”
About IQ Endoscopes
IQ Endoscopes is a medical device company based in Chepstow, South Wales. They are a team of clinical, med tech and engineering specialists committed to creating clinically effective, high-performance single-use flexible endoscopes on a global scale.
Using a novel and patented engineering approach, the range of single use endoscopes will deliver much needed change within endoscopy, addressing the huge demand for the service globally. Their mission is to help endoscopists and their service providers improve their way of working, giving them greater flexibility, choice and control so they can increase capacity and ultimately save patients’ lives.
